2013 BRFSS Asthma Call-Back Survey Prevalence Tables

TABLE 3b. Estimated percent for time since first diagnosis among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013

State/Territory Sample
size±
5 or fewer years More than 5 years
Sample
size
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 137 23 N/A N/A (N/A – N/A) 114 82.1 6.3 (69.8 – 94.4)
Arizona 105 12 N/A N/A (N/A – N/A) 93 88.7 6.6 (75.8 – 100.0)
California 184 28 11.6 2.8 (6.1 – 17.1) 156 88.4 2.8 (82.9 – 93.9)
Connecticut 234 26 N/A N/A (N/A – N/A) 208 84.0 5.5 (73.2 – 94.8)
Florida 770 84 N/A N/A (N/A – N/A) 686 91.3 2.8 (85.8 – 96.8)
Georgia 131 19 N/A N/A (N/A – N/A) 112 82.4 6.5 (69.7 – 95.1)
Hawaii 110 17 N/A N/A (N/A – N/A) 93 68.2 10.8 (47.0 – 89.4)
Indiana 338 40 11.2 2.4 (6.5 – 15.9) 298 88.8 2.4 (84.1 – 93.5)
Iowa 213 32 8.9 2.1 (4.8 – 13.0) 181 91.1 2.1 (87.0 – 95.2)
Kansas 657 47 10.3 2.9 (4.6 – 16.0) 610 89.7 2.9 (84.0 – 95.4)
Kentucky 364 56 16.4 3.8 (9.0 – 23.8) 308 83.6 3.8 (76.2 – 91.0)
Louisiana 144 17 N/A N/A (N/A – N/A) 127 89.1 4.5 (80.3 – 97.9)
Maine 241 31 9.2 2.4 (4.5 – 13.9) 210 90.8 2.4 (86.1 – 95.5)
Maryland 247 41 27.3 6.4 (14.8 – 39.8) 206 72.7 6.4 (60.2 – 85.2)
Massachusetts 150 23 18.4 5.5 (7.6 – 29.2) 127 81.6 5.5 (70.8 – 92.4)
Michigan 494 57 9.8 2.0 (5.9 – 13.7) 437 90.2 2.0 (86.3 – 94.1)
Mississippi 217 34 N/A N/A (N/A – N/A) 183 69.7 9.5 (51.1 – 88.3)
Missouri 221 27 10.1 2.6 (5.0 – 15.2) 194 89.9 2.6 (84.8 – 95.0)
Montana 280 29 6.7 2.0 (2.8 – 10.6) 251 93.3 2.0 (89.4 – 97.2)
Nebraska 289 31 6.6 1.7 (3.3 – 9.9) 258 93.4 1.7 (90.1 – 96.7)
Nevada 114 16 N/A N/A (N/A – N/A) 98 92.5 2.7 (87.2 – 97.8)
New Hampshire 229 24 N/A N/A (N/A – N/A) 205 78.9 7.5 (64.2 – 93.6)
New Jersey 281 38 9.0 2.6 (3.9 – 14.1) 243 91.0 2.6 (85.9 – 96.1)
New Mexico 238 27 N/A N/A (N/A – N/A) 211 88.6 4.2 (80.4 – 96.8)
New York 113 15 N/A N/A (N/A – N/A) 98 92.5 2.7 (87.2 – 97.8)
North Carolina 123 12 N/A N/A (N/A – N/A) 111 96.2 1.4 (93.5 – 98.9)
Ohio 253 34 26.1 6.1 (14.1 – 38.1) 219 73.9 6.1 (61.9 – 85.9)
Oklahoma 234 30 7.1 1.6 (4.0 – 10.2) 204 92.9 1.6 (89.8 – 96.0)
Oregon 185 20 N/A N/A (N/A – N/A) 165 87.6 4.8 (78.2 – 97.0)
Pennsylvania 267 26 7.4 1.8 (3.9 – 10.9) 241 92.6 1.8 (89.1 – 96.1)
Rhode Island 210 31 15.6 4.6 (6.6 – 24.6) 179 84.4 4.6 (75.4 – 93.4)
Texas 234 30 N/A N/A (N/A – N/A) 204 91.7 3.1 (85.6 – 97.8)
Utah 325 55 21.6 5.7 (10.4 – 32.8) 270 78.4 5.7 (67.2 – 89.6)
Vermont 200 19 N/A N/A (N/A – N/A) 181 82.8 6.4 (70.3 – 95.3)
Washington 297 38 10.8 2.4 (6.1 – 15.5) 259 89.2 2.4 (84.5 – 93.9)
West Virginia 126 17 N/A N/A (N/A – N/A) 109 84.6 5.0 (74.8 – 94.4)
Wisconsin 190 24 N/A N/A (N/A – N/A) 166 88.4 4.2 (80.2 – 96.6)
Puerto Rico 246 32 11.4 3.2 (5.1 – 17.7) 214 88.6 3.2 (82.3 – 94.9)
38 state total 9,391 1,162 12.1 0.8 (10.5 – 13.7) 8,229 87.9 0.8 (86.3 – 89.5)
Median     10.6       88.7    
Range     6.6-27.3       68.2-96.2    

1 Aged ≥ 18 years

2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline sample size excludes “DK/Refused”

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30